ASIT Biotech

ASIT Biotech S.A. is a biopharmaceutical company based in Liège, Belgium, specializing in the research, development, and commercialization of immunotherapy products aimed at treating allergies. The company's lead product, gp-ASIT+, is currently undergoing Phase III trials for grass pollen rhinitis. Additionally, ASIT Biotech is developing hdm-ASIT+ for house dust mite asthma and pnt-ASIT+ for peanut allergy. Founded in 1997 and formerly known as BioTech Tools SA, the company has focused on utilizing its ASIT+ technology platform to create breakthrough immunotherapy solutions for allergy patients.

Michel Baijot Ph.D

CEO and Board Member

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.